Skip to main content
. 2019 May 1;53(3):216–222. doi: 10.1007/s13139-019-00594-x

Table 1.

Patients’ characteristics

Patients 204 (♀ 86, ♂ 118) Average Range
Age (years) 64.8 25–91
BMI (kg/cm2) 26.3 14.7–38.9
Glycemia (mg/ml) 103.5 52–232
Injected dose (MBq) 296 133–494
Uptake time (min) 59 51–100

Clinical indications

  Oncological: 199

  Non-oncological: 5

Follow-up (months) 5.3 3–12